SARS-CoV-2 and bioimmunotherapy for ulcerative colitis

扫码查看

原文链接

NETL
NSTL
万方数据
维普

外文摘要：Novel coronavirus (SARS‑CoV‑2, SARS‑CoV‑2 for short) infection can cause a series of gastrointestinal damage. Related studies have reported that SARS‑CoV‑2 infection can lead to the occurrence and progression of ulcerative colitis , which may be related to the cytokine storm caused by SARS‑CoV‑2 infection. Recently, we have also paid attention to whether infection with SARS‑CoV‑2 will aggravate the condition of UC patients receiving biological immunotherapy and whether vaccination with SARS‑CoV‑2 is safe and effective for these patients. At present, the interaction mechanism between SARS‑CoV‑2, SARS‑CoV‑2 vaccine and ulcerative colitis is not fully understood, and more research is needed to further clarify the relationship.

外文关键词：

SARS‑CoV‑2Ulcerative colitisBiologicsImmunosuppressantsSARS‑CoV‑2 vaccineTherapyProgress

作者：

KANG Yin-nan、JIE You-cheng、LIU Shan-shan、WANG Jun-ke、LI Chu-yi、YU Xiao-hui、ZHANG Jiu-cong

展开 >

作者单位：

The Second District of the Department of Gastroenterology,No.940 Hospital,Joint Logistics Support Force of the Chinese People's Liberation Army,Lanzhou 730050,China

The First Clinical Medical College of Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China

基金：

In?Hospital Fund Project of No.940 HospitalGeneral Research Fund Project of Huoshenshan HospitalGansu Provincial Science and Technology Department Social Development Department Clinical Medicine Research Center Project

项目编号：

20yjky020HSS?21721JR7RA017

出版年：

2022

海南医科大学学报(英文版)

ISSN：

年,卷(期)：2022.28(16)

参考文献量57